Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma

NCT02248402 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: Vax-DC/MM

Sponsor

Chonnam National University Hospital